In contrast, in a separate clinical study, PV001-DV induced high activation of cell populations of CD4 and CD8 T cells, NK and NK-T cells, alongside other known anti-cancer effector cells such as γδ T cells [63]. The gene discussed is CD8A; the disease is cancer.